Nav: Home

Physical inactivity cost the world $67 billion in 2013 says first ever estimate

July 27, 2016

A world-first study has revealed that in 2013, physical inactivity cost INT $67.5 billion* globally in healthcare expenditure and lost productivity, revealing the enormous economic burden of an increasingly sedentary world.

The study, published today in The Lancet, was led by Dr Melody Ding from University of Sydney, leader of the current Lancet physical activity series.

This study provides the first-ever global estimate of the financial cost of physical inactivity by examining the direct health-care cost, productivity losses, and disability-adjusted life years (DALYs) for five major non-communicable diseases attributable to inactivity: coronary heart disease, stroke, type 2 diabetes, breast cancer and colon cancer.

Based on data from 142 countries, representing 93.2 per cent of the world's population, the researchers conservatively estimated that in 2013 the effect of physical inactivity on these diseases and all-cause mortality cost the world economy more than INT$67.5 billion.

"Physical inactivity is recognised as a global pandemic that not only leads to diseases and early deaths, but imposes a major burden to the economy," said lead author Dr Melody Ding, Senior Research Fellow from the University's School of Public Health.

"Based on our data, physical inactivity costs the global economy INT67.8 billion in 2013, with Australia footing a bill of more than AUD $805 million. At a global and individual country level these figures are likely to be an underestimate of the real cost, because of the conservative methodologies used by the team and lack of data in many countries.

Counting the cost of global of inactivity: 2013 (International dollars)

$67.5bn: Total costs, including $53.8bn in direct cost (healthcare expenditure) and 13.7bn in indirect costs (productivity losses)
$31.2bn: Total loss in tax revenue through public healthcare expenditure
$12.9bn: Total amount in private sector pays for physical inactivity-related diseases (e.g. health insurance companies)
$9.7bn: Total amount households paid out-of-pocket for physical inactivity-related diseases

Type 2 Diabetes was the costliest disease, accounting for $37.6bn (70pc) of direct costs.

Counting the cost of global of inactivity in Australia: 2013 (Australian dollars)

AUD$805m: Total costs, including AUD$640m in direct costs (healthcare expenditure) and AUD$165m in indirect costs (loss in productivity)
AUD$425m: Total loss in tax revenue through public healthcare expenditure
AUD$91m: Total amount in private sector pays for physical inactivity-related diseases (e.g. health insurance companies)
AUD$124m: Total amount households paid out-of-pocket for physical inactivity-related diseases

"Our study has shown that the economic burden of physical inactivity is distributed unequally across regions, and disproportionately with high-income countries bearing a larger proportion of economic burden and low and middle-income countries having a larger proportion of the disease burden," Dr Ding said.

"Generally, poorer countries don't have their health needs met due to less developed health and economic systems. Ultimately, poor households pay the most in terms of premature death and disease, showing inequalities. As these countries develop economically, so too will the consequent economic burden, if the pandemic of physical inactivity spreads as expected.

"Globally, the economic burden of physical inactivity is projected to increase, particularly in low and middle-income countries, if no action is taken to improve population levels of physical activity.

"It's also important to consider where the economic burden falls, including on the public sector, private sector, and out-of-pocket household expenditures.

"This study provides a better understanding of the true burden of the pandemic of physical inactivity, and provides useful information for policy making, funding allocation and benchmarking in global prevention of non-communicable diseases," she said.

Professor Adrian Bauman, University of Sydney, and member of the Lancet Physical Activity Series Steering Committee said: "This research provides further justification to prioritise promotion of regular physical activity worldwide as part of a comprehensive strategy to reduce non-communicable diseases."

"Increasing physical activity levels in communities is an important investment that governments should consider which could lead to savings in healthcare costs and more productivity in the labour market."
-end-
*INT = International dollars - $67.5 billion equivalent to $67.5 billion USD could buy in the USA in 2013.

University of Sydney

Related Diabetes Articles:

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.
Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.
Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).
Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.
People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.
Diabetes, but not diabetes drug, linked to poor pregnancy outcomes
New research indicates that pregnant women with pre-gestational diabetes who take metformin are at a higher risk for adverse pregnancy outcomes -- such as major birth defects and pregnancy loss -- than the general population, but their increased risk is not due to metformin but diabetes.
New oral diabetes drug shows promise in phase 3 trial for patients with type 1 diabetes
A University of Colorado Anschutz Medical Campus study finds sotagliflozin helps control glucose and reduces the need for insulin in patients with type 1 diabetes.
Can continuous glucose monitoring improve diabetes control in patients with type 1 diabetes who inject insulin
Two studies in the Jan. 24/31 issue of JAMA find that use of a sensor implanted under the skin that continuously monitors glucose levels resulted in improved levels in patients with type 1 diabetes who inject insulin multiple times a day, compared to conventional treatment.
Complications of type 2 diabetes affect quality of life, care can lead to diabetes burnout
T2D Lifestyle, a national survey by Health Union of more than 400 individuals experiencing type 2 diabetes (T2D), reveals that patients not only struggle with commonly understood complications, but also numerous lesser known ones that people do not associate with diabetes.
A better way to predict diabetes
An international team of researchers has discovered a simple, accurate new way to predict which women with gestational diabetes will develop type 2 diabetes after delivery.
More Diabetes News and Diabetes Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.